Diabetes Mellitus, Insulin-Dependent
|
0.410 |
GeneticVariation
|
disease |
GWASCAT |
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.
|
25751624 |
2015 |
Diabetes Mellitus, Insulin-Dependent
|
0.410 |
GeneticVariation
|
disease |
GWASDB |
A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci.
|
21980299 |
2011 |
Diabetes Mellitus, Insulin-Dependent
|
0.410 |
GeneticVariation
|
disease |
BEFREE |
A marker at one other locus, C1QTNF6, previously associated with T1D, showed nominal association with RA in the current study but did not remain statistically significant at the corrected threshold.
|
20854658 |
2010 |
Diabetes Mellitus, Insulin-Dependent
|
0.410 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.
|
19430480 |
2009 |
Diabetes Mellitus, Insulin-Dependent
|
0.410 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.
|
19430480 |
2009 |
Diabetes Mellitus, Insulin-Dependent
|
0.410 |
GeneticVariation
|
disease |
GWASDB |
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.
|
18978792 |
2008 |
Diabetes Mellitus, Insulin-Dependent
|
0.410 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.
|
18978792 |
2008 |
Diabetes Mellitus, Insulin-Dependent
|
0.410 |
Biomarker
|
disease |
CTD_human |
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.
|
18978792 |
2008 |
Diabetes, Autoimmune
|
0.300 |
Biomarker
|
disease |
CTD_human |
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.
|
18978792 |
2008 |
Brittle diabetes
|
0.300 |
Biomarker
|
disease |
CTD_human |
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.
|
18978792 |
2008 |
Diabetes Mellitus, Ketosis-Prone
|
0.300 |
Biomarker
|
disease |
CTD_human |
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.
|
18978792 |
2008 |
Diabetes Mellitus, Sudden-Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.
|
18978792 |
2008 |
Graves Disease
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
We found both the rs229527 allele within C1QTNF6 (odds ratio [OR] = 1.23, confidence interval [95% CI]: 1.12-1.33, p<sub>Allelic</sub> = 4.60 × 10<sup>-6</sup>) and the rs2284038 allele within RAC2 (OR = 1.10, 95% CI: 1.01-0.19, p<sub>Allelic</sub> = 3.00 × 10<sup>-2</sup>) showed significant associations with GD susceptibility.
|
28665696 |
2017 |
Graves Disease
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
In this study, we carried out a three-stage study in 9529 patients with GD and 9984 controls to identify new risk loci for GD and found genome-wide significant associations in the overall populations for five novel susceptibility loci: the GPR174-ITM2A at Xq21.1, C1QTNF6-RAC2 at 22q12.3-13.1, SLAMF6 at 1q23.2, ABO at 9q34.2 and an intergenic region harboring two non-coding RNAs at 14q32.2 and one previous indefinite locus, TG at 8q24.22 (Pcombined < 5 × 10(-8)).
|
23612905 |
2013 |
Graves Disease
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis.
|
23612905 |
2013 |
Graves Disease
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis.
|
23612905 |
2013 |
Autoimmune Diseases
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Hypothyroidism
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Lupus Erythematosus, Systemic
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Transancestral mapping and genetic load in systemic lupus erythematosus.
|
28714469 |
2017 |
Vitiligo
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.
|
27723757 |
2016 |
Vitiligo
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.
|
22561518 |
2012 |
Multiple Sclerosis
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
|
22190364 |
2011 |